Stock RXST RXSIGHT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company RxSight, Inc.

Equities

RXST

US78349D1072

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
52.84 USD -3.79% Intraday chart for RxSight, Inc. +0.02% +31.05%
Apr. 04 RxSight Launches New Light Adjustable Lens Product MT
Apr. 04 RxSight, Inc. Announces Commercial Launch of its Newest Light Adjustable Lens??, the LAL+??, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting CI

Business Summary

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Number of employees: 374

Sales per Business

USD in Million2022Weight2023Weight Delta
Light Adjustable Lenses and Related Capital Equipment
100.0 %
49 100.0 % 89 100.0 % +81.77%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
49 100.0 % 89 100.0 % +81.77%

Managers

Managers TitleAgeSince
Ronald Kurtz CEO
 Chief Executive Officer 60 15-05-31
Shelley Thunen DFI
 Director of Finance/CFO 72 15-12-31
Maureen O'Connell CTO
 Chief Tech/Sci/R&D Officer - -
Matt Haller CTO
 Chief Tech/Sci/R&D Officer - 13-04-30
Ilya Goldshleger COO
 Chief Operating Officer 49 15-08-31
Christian A. Sandstedt CTO
 Chief Tech/Sci/R&D Officer - 00-02-29
Rebecca Williston AUD
 Comptroller/Controller/Auditor - -
Steve Everly SAM
 Sales & Marketing - 21-08-16
Caroline Vaughn HRO
 Human Resources Officer - 22-01-31
Roy Freeman SAM
 Sales & Marketing - 21-12-31

Members of the board

Members of the board TitleAgeSince
Robert Palmisano BRD
 Director/Board Member 79 21-08-09
Bill Link BRD
 Director/Board Member 78 16-10-31
Ronald Kurtz CEO
 Chief Executive Officer 60 15-05-31
J. Corley CHM
 Chairman 68 14-12-31
Juliet Bakker BRD
 Director/Board Member 62 14-12-31
Julie Andrews BRD
 Director/Board Member 52 21-08-09
Shweta Singh Maniar BRD
 Director/Board Member 40 21-12-30
Robert Warner BRD
 Director/Board Member 57 21-08-09
Tamara Fountain BRD
 Director/Board Member 61 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 36,987,556 30,174,700 ( 81.58 %) 0 81.58 %

Shareholders

NameEquities%Valuation
RA Capital Management LP
9.204 %
3,404,285 9.204 % 176 M $
Artisan Partners Holdings LP
6.477 %
2,395,672 6.477 % 124 M $
Bruce Robertson
5.434 %
2,010,037 5.434 % 104 M $
Lord, Abbett & Co. LLC
5.345 %
1,977,000 5.345 % 102 M $
BlackRock Advisors LLC
5.270 %
1,949,268 5.270 % 101 M $
Richard Wolfen
4.940 %
1,827,349 4.940 % 94 M $
Vanguard Fiduciary Trust Co.
4.012 %
1,484,010 4.012 % 77 M $
Fidelity Management & Research Co. LLC
3.208 %
1,186,477 3.208 % 61 M $
Morgan Stanley Investment Management, Inc.
2.901 %
1,073,062 2.901 % 55 M $
T. Rowe Price Investment Management, Inc.
2.590 %
958,105 2.590 % 49 M $

Company contact information

RxSight, Inc.

100 Columbia

92656, Aliso Viejo

+

http://rxsight.com/
address RxSight, Inc.(RXST)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Ratings for RxSight, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
52.84 USD
Average target price
62.62 USD
Spread / Average Target
+18.52%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
RXSIGHT, INC. Stock RxSight, Inc.
+31.05% 1.95B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.89% 185B
MEDTRONIC PLC Stock Medtronic plc
-2.43% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.10% 67.55B
DEXCOM, INC. Stock DexCom, Inc.
+11.10% 54.6B
CENCORA, INC. Stock Cencora, Inc.
+15.86% 47.42B
HOYA CORPORATION Stock Hoya Corporation
+3.86% 42.24B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+9.55% 28.24B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.85% 26.42B
TERUMO CORPORATION Stock Terumo Corporation
+12.40% 25.66B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. RXST Stock
  4. Company RxSight, Inc.